WSG ADAPT – adjuvant dynamic marker-adjusted personalized therapy trial optimizing risk assessment and therapy response prediction in early breast cancer: study protocol for a prospective, multicenter, controlled, non-blinded, randomized, investigator initiated phase II / III trial - Hofmann, D; Nitz, U; Gluz, O (Trials, 2013)
et al.